---
figid: PMC11487528__or-52-06-08821-g03
figtitle: COL10A1 in malignant tumors
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11487528
filename: or-52-06-08821-g03.jpg
figlink: /pmc/articles/PMC11487528/figure/F4/
number: F4
caption: Role of COL10A1 in malignant tumors. TUG1 inhibits miR-144-3p to enhance
  COL10A1 transcription, while miR-384 and extracellular vesicle-contained miR-101-3p
  suppress COL10A1 transcription. COL10A1, via the TGF-β1/SMAD, FAK, MAPK and Wnt2
  signaling pathways, and targeted action against P4HB, promotes tumor cell proliferation.
  Additionally, COL10A1 promotes METTL3 expression, which upregulates the methylation
  of COL10A1 itself, thereby further facilitating tumorigenesis. The figure was generated
  using Figdraw. COL10A1, collagen type X α1 chain; DDR2, discoidin domain receptor
  tyrosine kinase 2; EMT, epithelial-mesenchymal transition; FAK, focal adhesion kinase;
  FAP, fibroblast activation protein; FN1, fibronectin 1; LEF1, lymphoid enhancer
  binding factor 1; METTL3, methyltransferase-like 3; miR, microRNA; P4HB, prolyl
  4-hydroxylase subunit β; TUG1, taurine upregulated gene 1; VSNL1, visinin-like protein
  1
papertitle: Oncogenic mechanisms of COL10A1 in cancer and clinical challenges (Review)
reftext: Qiang Yi, et al. Oncol Rep. 2024 Dec;52(6).
year: '2024'
doi: 10.3892/or.2024.8821
journal_title: Oncology Reports
journal_nlm_ta: Oncol Rep
publisher_name: Spandidos Publications
keywords: COL10A1 | oncogenic function | mechanism | malignant cancer | biological
automl_pathway: 0.9420332
figid_alias: PMC11487528__F4
figtype: Figure
redirect_from: /figures/PMC11487528__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11487528__or-52-06-08821-g03.html
  '@type': Dataset
  description: Role of COL10A1 in malignant tumors. TUG1 inhibits miR-144-3p to enhance
    COL10A1 transcription, while miR-384 and extracellular vesicle-contained miR-101-3p
    suppress COL10A1 transcription. COL10A1, via the TGF-β1/SMAD, FAK, MAPK and Wnt2
    signaling pathways, and targeted action against P4HB, promotes tumor cell proliferation.
    Additionally, COL10A1 promotes METTL3 expression, which upregulates the methylation
    of COL10A1 itself, thereby further facilitating tumorigenesis. The figure was
    generated using Figdraw. COL10A1, collagen type X α1 chain; DDR2, discoidin domain
    receptor tyrosine kinase 2; EMT, epithelial-mesenchymal transition; FAK, focal
    adhesion kinase; FAP, fibroblast activation protein; FN1, fibronectin 1; LEF1,
    lymphoid enhancer binding factor 1; METTL3, methyltransferase-like 3; miR, microRNA;
    P4HB, prolyl 4-hydroxylase subunit β; TUG1, taurine upregulated gene 1; VSNL1,
    visinin-like protein 1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDH1
  - FZR1
  - CDH2
  - ITK
  - SLC22A3
  - EPHB2
  - MAPK1
  - MAPK3
  - WNT2
  - TGFB1
  - AKT1
  - AKT2
  - AKT3
  - PTK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - FN1
  - P4HB
  - SMAD2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD3
  - DDR2
  - COL10A1
  - FAP
  - CEL
  - GLMN
  - NFKB1
  - MIR384
  - LEF1
  - SOX9
  - METTL3
  - TUG1
  - VSNL1
  - MEK
  - FAP
  - Nucleus
  - mRNA
---
